Gonadal function in young patients successfully treated for Hodgkin disease

Medical and Pediatric Oncology

Volumn 32, Issue 5, 1999, Pages 366-372

  Papadakis, Vassilios ^a   Vlachopapadopoulou, Elpis ^b   Van Syckle, Karen ^a   Ganshaw, Lee ^a   Kalmanti, Maria ^c   Tan, Charlotte ^a   Sklar, Charles ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^c UNIVERSITY OF CRETE   (Greece)

Author keywords

Gonadal function; Hodgkin disease; Late effects

Indexed keywords

CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DOXORUBICIN; FOLLITROPIN; LUTEINIZING HORMONE; PREDNISOLONE; PROCARBAZINE; TESTOSTERONE; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; FEMALE; FERTILITY; FOLLITROPIN BLOOD LEVEL; FUNCTIONAL ASSESSMENT; GONAD FUNCTION; HODGKIN DISEASE; HORMONE BLOOD LEVEL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEYDIG CELL; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; OVARY FUNCTION; PRIORITY JOURNAL; TESTIS FUNCTION; TESTOSTERONE BLOOD LEVEL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; FOLLOW-UP STUDIES; HODGKIN DISEASE; HUMANS; MALE; OVARIAN DISEASES; OVARY; PREDNISONE; PROCARBAZINE; TESTICULAR DISEASES; TESTIS; VINCRISTINE;

EID: 0033008928     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-911X(199905)32:5<366::AID-MPO10>3.0.CO;2-7     Document Type: Article

References (40)

1. Donaldson SS. Lessons from our children. Int J Radial Oncol Biol Phys 1993;26:739-749.
2. DeLaat CA, Lampkin BC. Long-term survivors of childhood cancer: evaluation and identification of sequelae of treatment. CA 1992;42:263-282.
3. Tan CTC. Hodgkin's disease in children and adolescents: experiences from the Memorial Sloan-Ketteririg Cancer Center, New York. In: Humphrey GB, Kamps WA, editor. Pediatric oncology IV: controversies and current practice in Hodgkin's disease. Boston: Kluwer Academic Publishers; 1987. P 291-302.
4. Donaldson SS, Kaplan HS. Complications of treatment of Hodgkin's disease in children. Cancer Treat Rep 1982;66:977-989.
5. Bramswig JH, Heimes U, Heiermann E, et al. The effects of different cumulative doses of chemotherapy on testicular function: results in 75 patients treated for Hodgkin's disease during childhood and adolescence. Cancer 1990;65:1298-1302.
6. Schwartz CL. Creating life on the plateau: reproductive potential in survivors of childhood Hodgkin's disease. Int J Radiat Oncol Biol Phys 1990;19:1099-1100.
7. da Cunha MF, Meistrich ML, Fuller LM, et al. Recovery of spermatogenesis after treatment for Hodgkin's disease: limiting dose of MOPP chemotherapy. J Clin Oncol 1982:571-574.
8. Sherins RJ, Olweny CLM, Ziegler JL. Gynecomastia and gonadal dysfunction in adolescent boys treated with combination chemotherapy for Hodgkin's desease. N Engl J Med 1978;299:12-16.
9. Mackie EJ, Radford M, Shalet SM. Gonadal function following chemotherapy for childhood Hodgkin's disease. Med Pediatr Oncol 1996;27:74-78.
10. Horning SJ, Hoppe RT, Kaplan HS, Rosenberg SA. Female reproductive potential after treatment for Hodgkin's disease. N Engl J Med 1981;304:1377-1382.
11. Kreuser ED, Xiros N, Hetzel WD, Heimpel H. Reproductive and endocrine gonadal capacity in patients treated with COPP chemotherapy for Hodgkin's disease. J Cancer Res Clin Oncol 1987; 113:260-266.
12. Waxman JHX, Terry YA, Wrigley PFM, et al. Gonadal function in Hodgkin's disease: long-term follow-up of chemotherapy. Br Med J 1982;285:1612-1613.
13. Holmes SJ, Whitehouse RW, Clark ST, et al. Reduced bone density in men following chemotherapy for Hodgkin's disease. Br J Cancer 1994;70:371-375.
14. Chapman RM, Sutcliffe SB, Malpas JS. Male gonadal dysfunction in Hodgkin's disease: a prospective study. JAMA 1981;245:1323-1328.
15. Heikens J, Behrendt H, Adriaanse R, Berghout A. Irreversible gonadal damage in male survivors of pediatric Hodgkin's disease. Cancer 1996;78:2020-2024.
16. Bramswig JH, Heiermann E, Heimes U, et al. Ovarian function in 63 girls treated for Hodgkin's disease (HD) according to the West-German DAL-HD-78 and DAL-HD-82 therapy study. Med Pediatr Onccol 1989;17:344.
17. Sy Ortin TT, Shostak CA, Donaldson SS. Gonadal status and reproductive function following treatment for Hodgkin's disease in childhood: the Stanford experience. Int J Radiat Oncol Biol Phys 1990;19:873-880.
18. Hudson MM, Greenwald C, Thompson E, et al. Efficacy and toxicity of multiagent chemotherapy and low-dose involved-field radiotherapy in children and adolescents with Hodgkin's disease. J Clin Oncol 1993;11:100-108.
19. Tan CTC, Chan KAW. Hodgkin's Disease. Pediatr Ann 1983;12: 306-321.
20. Tan C, Jereb B, Chan KAW, et al. Hodgkin's disease in children: results of management between 1970-1981. Cancer 1983;51: 1720-1725.
21. Cham WCC, Tan CTC, Martinez A, et al. Involved field radiation therapy for early stage Hodgkin's disease in children: preliminary results. Cancer 1976;37:1625-1632.
22. Jereb B, Tan C, Bretsky S, et al. Involved field (IF) irradiation with or without chemotherapy in the management of children with Hodgkin's disease. Med Pediatr Oncol 1984;12:325-332.
23. Marshall WA, Tanner JM. Variations in the pattern of puberal changes in girls. Arch Dis Child 1969;44:291-298.
24. Marshall WA, Tanner JM. Variations in the pattern of puberal changes in boys. Arch Dis Child 1970;45:13-17.
25. Chapman RM, Sutcliffe SB, Malpas JS. Cytotoxic-induced ovarian failure in women with Hodgkin's disease. JAMA 1979;242: 1877-1881.
26. Andrieu JM, Ochoa-Molina E. Menstrual cycle, pregnancies and offspring before and after MOPP therapy for Hodgkin's disease. Cancer 1983;52:435-438.
27. Schilsky RL, Sherins RL, Hubbard SM, et al. Long-term follow-up of ovarian function in women treated with MOPP chemotherapy for Hodgkin's disease. Am J Med 1981;71:552-556.
28. Green DM, Brecher ML, Linsday AN, et al. Gonadal function in pediatric patients following treatment for Hodgkin disease. Med Pediar Oncol 1981;9:235-244.
29. Shafford EA, Kingston JE, Malpas JS, et al. Testicular function following treatment of Hodgkin's disease in childhood. Br J Cancer 1993;68:119-1204.
30. Dhabhar BN, Malhotra H, Joseph R, et al. Gonadal function in prepubertal boys following treatment for Hodgkin's disease. Am. J Pediatr Hematol Oncol 1993;15:306-310.
31. Watson AR, Rance CP, Bain J. Longterm effects of cyclophosphamide on testicular function. Br Med J 1985;291:1457-1460.
32. De Kretser DM, Burger HG, Hudson B. The relationship berween germinal cells and serum FSH levels in males with infertility. J Clin Endocrinol Metab 1974;38:787-793.
33. Redman JR, Bajorunas DR, Goldstein MC, et al. Semen cryopreservation and artificial insemination for Hodgkin's disease. J Clin Oncol 1987;5:233-238.
34. Vigersky RA, Chapman RM, Berenberg J, Glass AR. Testicular dysfunction in untreated Hodgkin's disease. Am J Med 1982;73: 482-486.
35. Sklar CA, Robison LL, Nesbit ME, et al. Effects of radiation on testicular function in long-term survivors of childhood acute lymphoblastic leukemia: a report from the Children's Cancer Study Group. J Clin Oncol 1993;8:1981-1987.
36. Nasir J, Wallon C, Lindow SW, Masson EA. Spontaneous recovery of chemotherapy-induced primary ovarian failure: implications for management. Clin Endocrinol 1997;46:217-219.
37. Davies MC, Hall ML, Jacobs HS. Bone mineral loss in young women with amenorrhoea. Br Med J 1990;301:790-793.
38. Thibaud E, Ramirez M, Brauner R, et al. Preservation of ovarian function by ovarian transposition performed before pelvic irradiation during childhood. J Pediatr 1992;121:880-884.
39. Kliesch S, Behre HM, Jurgens H, Nieschlag E. Cryopreservation of semen from adolescent patients with malignancies. Med Pediar Oncol 1996;26:20-27.
40. Sanger WG, Olson JH, Sherman JK. Semen cryobanking for men with cancer: criteria change. Fertil Steril 1992;58:1024-1027.